Repurposing tromethamine as inhaled therapy to treat CF airway disease

Overview of attention for article published in JCI Insight, June 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 56,095 followers.

RT @vamsee_raju: Most common laboratory buffer Tris (THAM) as inhaled therapy to treat CF airway disease. @jcinews @ATS_RCMB https://t.co/…

Most common laboratory buffer Tris (THAM) as inhaled therapy to treat CF airway disease. @jcinews @ATS_RCMB https://t.co/LvW4IroTOj

RT @jclinicalinvest: JCI insight: Repurposing an old drug to treat #CysticFibrosis airway disease https://t.co/QREs29gMZn @uiowa https://t.…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.